IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atle Fund Management AB

Q4 2015 Holdings

Filed 2016-01-11 | 14 holdings | $29.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Charles RIV Labs Intl Inc(CRL)COM159864107$14.7M182,70750.1%
Anika Therapeutics Inc(ANIK)COM035255108$14.5M378,74549.3%
Lifepoint Health IncCOM53219L109$27.4K373,4300.1%
GNC Hldgs IncCOM CL A36191G107$25.5K821,1900.1%
Gilead Sciences Inc(GILD)COM375558103$23.2K229,3000.1%
Amag Pharmaceuticals Inc(AMAG)COM00163U106$15.7K520,0000.1%
Magellan Health IncCOM NEW559079207$15.3K248,9340.1%
Varian MED SYS Inc(VAREUR)COM92220P105$14.9K184,0000.1%
Anthem Inc(ELV)COM036752103$14.7K105,7000.1%
Triple-S Mgmt Corp(GTS)CL B896749108$14.5K606,9440.0%
FEI CoCOM30241L109$14.3K178,7630.0%
Supernus Pharmaceuticals Inc(SUPN)COM868459108$14.1K1,051,2770.0%
Symmetry Surgical IncCOM87159G100$2.7K298,4270.0%
Immucell Corp(ICCC)COM PAR $0.10452525306$945125,2920.0%